1-8 of 8
Kitsada Wudhikarn
Close
Sort by
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Clinical Trials & Observations
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R. Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanova, Loretta J. Nastoupil, Joseph P. McGuirk, Richard T. Maziarz, Olalekan O. Oluwole, Stephen J. Schuster, David L. Porter, Michael R. Bishop, Peter A. Riedell, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3192–3198.
https://doi.org/10.1182/bloodadvances.2022008294
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab

Clinical Trials & Observations
Kitsada Wudhikarn, Amber C. King, Mark B. Geyer, Mikhail Roshal, Yvette Bernal, Boglarka Gyurkocza, Miguel-Angel Perales, Jae H. Park
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1432–1443.
https://doi.org/10.1182/bloodadvances.2021005978
Published: 2022
Includes: Supplemental data
Journal Articles

SF3B1 -mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia–free survival

Clinical Trials & Observations
Kitsada Wudhikarn, Sanam Loghavi, Abhishek A. Mangaonkar, Aref Al-Kali, Moritz Binder, Ryan Carr, Kaaren Reichard, Christy Finke, Matthew Howard, Naseema Gangat, Ayalew Tefferi, Rami Komrokji, Najla Ali, Terra Lasho, Rhett Ketterling, Eric Padron, Mrinal M. Patnaik
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5716–5721.
https://doi.org/10.1182/bloodadvances.2020003345
Published: 2020
Includes: Supplemental data
Journal Articles

DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality

Clinical Trials & Observations
Kitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, Jessica R. Flynn, Aishat Afuye, Mari Lynne Silverberg, Molly A. Maloy, Sean M. Devlin, Connie Lee Batlevi, Gunjan L. Shah, Michael Scordo, Maria Lia Palomba, Parastoo B. Dahi, Craig S. Sauter, Bianca D. Santomasso, Elena Mead, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3024–3033.
https://doi.org/10.1182/bloodadvances.2020001972
Published: 2020
Includes: Supplemental data
Journal Articles

Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management

Clinical Trials & Observations
Martina Pennisi, Tania Jain, Bianca D. Santomasso, Elena Mead, Kitsada Wudhikarn, Mari Lynne Silverberg, Yakup Batlevi, Roni Shouval, Sean M. Devlin, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Molly Maloy, Maria Lia Palomba, Miriam Sanchez-Escamilla, Craig S. Sauter, Michael Scordo, Gunjan Shah, Jae H. Park, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2020) 4 (4): 676–686.
https://doi.org/10.1182/bloodadvances.2019000952
Published: 2020
Journal Articles

The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease

Clinical Trials & Observations
Hrishikesh K. Srinagesh, Umut Özbek, Urvi Kapoor, Francis Ayuk, Mina Aziz, Kaitlyn Ben-David, Hannah K. Choe, Zachariah DeFilipp, Aaron Etra, Stephan A. Grupp, Matthew J. Hartwell, Elizabeth O. Hexner, William J. Hogan, Alexander B. Karol, Stelios Kasikis, Carrie L. Kitko, Steven Kowalyk, Jung-Yi Lin, Hannah Major-Monfried, Stephan Mielke, Pietro Merli, George Morales, Rainer Ordemann, Michael A. Pulsipher, Muna Qayed, Pavan Reddy, Ran Reshef, Wolf Rösler, Karamjeet S. Sandhu, Tal Schechter, Jay Shah, Keith Sigel, Daniela Weber, Matthias Wölfl, Kitsada Wudhikarn, Rachel Young, John E. Levine, James L. M. Ferrara
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4034–4042.
https://doi.org/10.1182/bloodadvances.2019000791
Published: 2019
Includes: Supplemental data
Journal Articles

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma

Chantana Polprasert, Yasuhide Takeuchi, Nobuyuki Kakiuchi, Kenichi Yoshida, Thamathorn Assanasen, Wimonmas Sitthi, Udomsak Bunworasate, Arunrat Pirunsarn, Kitsada Wudhikarn, Panisinee Lawasut, Noppacharn Uaprasert, Sunisa Kongkiatkamon, Chatphatai Moonla, Masashi Sanada, Nobuhiro Akita, June Takeda, Yoichi Fujii, Hiromichi Suzuki, Yasuhito Nannya, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Ponlapat Rojnuckarin, Seishi Ogawa, Hideki Makishima
Journal: Blood Advances
Blood Adv (2019) 3 (4): 588–595.
https://doi.org/10.1182/bloodadvances.2018028340
Published: 2019
Includes: Supplemental data